22
https://pubmed.ncbi.nlm.nih.gov/38112467
The post-COVID-19 population and mRNA vaccination can induce cross-reactive antibodies against various coronavirus spike proteins, potentially contributing to cross-protection from severe disease caused by novel coronaviruses.